In this report, we present a case of exacerbation of cold agglutinin syndrome (CAS) potentially due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia. An 83-year-old female with a history of cold agglutinin hemolytic anemia presented with shortness of breath, productive cough, worsening orthopnea, darkening fingers and urine, and jaundice. Laboratory investigations found elevated white blood cells (WBC) and total bilirubin, severely low hemoglobin, and positive direct Coombs test. Moreover, SARS-CoV-2 RNA was also found to be positive in a sample from the nasal swab by reverse transcription-polymerase chain reaction (RT-PCR), indicating exacerbation of CAS secondary to viral coronavirus 2019 (COVID-19) infection. A treatment regime for SARS-CoV-2 consisting of five days of remdesivir and seven days of dexamethasone 6 mg IV was initiated, resulting in significant improvement in the patient’s condition.
【저자키워드】 COVID-19, SARS-CoV-2, COVID-19 pneumonia, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), cold agglutinin syndrome, COVID-19 associated coagulopathy, covid coagulopathy, autoimmune hemolytic anemia (aiha), covid hypercoagulability, transfusion in covid 19 pandemic, 【초록키워드】 Treatment, coronavirus, Pneumonia, Infection, Remdesivir, cough, RT-PCR, White blood cell, female, Urine, WBC, hemoglobin, nasal swab, Coronavirus 2019, CAS, hemolytic anemia, Shortness of breath, acute respiratory syndrome, total bilirubin, worsening, syndrome, positive, jaundice, laboratory investigation, FIVE, Seven, resulting, the patient, elevated, initiated, dexamethasone 6 mg, 【제목키워드】 Cold, Exacerbation, setting, secondary, Agglutinin,